UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000050210 |
|---|---|
| Receipt number | R000056016 |
| Scientific Title | Fundamental survey registry research in the field of neurodegenerative diseases |
| Date of disclosure of the study information | 2023/02/01 |
| Last modified on | 2023/02/01 14:19:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Fundamental survey registry research in the field of neurodegenerative diseases
Acronym
Fundamental survey registry research in the field of neurodegenerative diseases
Scientific Title
Fundamental survey registry research in the field of neurodegenerative diseases
Scientific Title:Acronym
Fundamental survey registry research in the field of neurodegenerative diseases
Region
| Japan |
Condition
Condition
neurodegenerative diseases
Classification by specialty
| Neurology | Pediatrics | Psychiatry |
| Neurosurgery | Adult | Child |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
We will accumulate clinical information of patients in the area of neurodegenerative diseases and examine the evaluation items continuously and long-term.
Basic objectives2
Others
Basic objectives -Others
We will elucidate the natural history and prognostic factors of neurodegenerative diseases, and contribute to the development and establishment of new treatments for neurodegenerative diseases in the future.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The goal is to establish a continuous case accumulation system for patients with neurodegenerative diseases.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)Patients who have been diagnosed with possible disease according to each diagnostic criteria in the area of neurodegenerative diseases
2)Patients who gave written informed consent to participate in the study
Key exclusion criteria
1) Patients who are judged to be inappropriate as subjects by the judgment of researchers, etc.
Target sample size
99999
Research contact person
Name of lead principal investigator
| 1st name | Hisanori |
| Middle name | |
| Last name | Kowa |
Organization
National Hospital Organization Matsue Medical Center
Division name
Honorary Director
Zip code
690-8556
Address
5-8-31 Agenogi, Matsue-city, Shimane Pref., JAPAN
TEL
0852-21-6131
nakashima.kenji.np@mail.hosp.go.jp
Public contact
Name of contact person
| 1st name | Hisanori |
| Middle name | |
| Last name | Kowa |
Organization
National Hospital Organization Matsue Medical Center
Division name
Deputy Director
Zip code
690-8556
Address
5-8-31 Agenogi, Matsue-city, Shimane Pref., JAPAN
TEL
0852-21--6131
Homepage URL
norkowa-neu@umin.ac.jp
Sponsor or person
Institute
the Ministry of Health, Labour and Welfare
Institute
Department
Personal name
Funding Source
Organization
the Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kyoto University Graduate School and Faculty of Medicine, Ethics Committee
Address
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN
Tel
075-753-4680
ethcom@kuhp.kyoto-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 04 | Month | 15 | Day |
Date of IRB
| 2022 | Year | 04 | Month | 20 | Day |
Anticipated trial start date
| 2022 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 04 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This work has been supported by Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan
Management information
Registered date
| 2023 | Year | 02 | Month | 01 | Day |
Last modified on
| 2023 | Year | 02 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056016
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
